North America Diabetes Care Devices Market Key Players and Opportunities by 2027

The North America diabetes care devices market is expected to reach US$ 15,300.0 Mn in 2027 from US$ 8,936.5 Mn in 2018. The market is estimated to grow with a CAGR of 6.3% from 2019-2027.

The growth of the market is driven by the factors such as, growing geriatric population and rapid technological advancements in diabetes care devices. However, the diabetes care devices market is likely to get impacted due to high cost of diabetes care devices and risks associated with the insulin delivery devices in the region.

The pen needles attached to injection pens have been found to be re-used by the patients at a significant rate. One of the major reason behind this reuse is known to be the cost of these needles. Although the initial price of these pen needles are on a cheaper side, the existing prices are still a reason for lesser number of units sold as compared to the doses administered by patients on an average. According to a survey conducted by BD in determining the pattern of pen needle usage among population in 2014-2015, 23.3% participants in the survey reported reuse of pen needles due to the price of these needles as well as for cost-saving purposes. Thus, the market launch of affordable yet efficient pen needles is expected to be one of the potential opportunities that can be utilized by the market players to increase their sales and thereby establish a significant position in the highly competitive pen needles market. Few of the top companies have also started taking steps towards development and launch of such products in the market. For instance, in July 2017, Becton, Dickinson and Company (BD), as a part of action of the Health Service Medical Supplies Act 2017, launched Viva insulin pen needles as a cost effective option for people with diabetes to accommodate extreme budgetary pressure on the National Health Services (NHS). The company aimed to ensure presence of cost-effective options for high-quality pen needles in the UK. Various similar launches are expected to provide growth opportunities to emerging and local players in the global pen needles market.

US is expected to lead the market in the North America region owing to rise in the prevalence of the diabetes and growing elder population in the region. However, the country lags behind the other developed countries that can be a restrain to the market growth. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.

 
NORTH AMERICA DIABETES CARE DEVICES – MARKET SEGMENTATION

By Product

• Glucose Monitoring Devices

• • Glucometers
  • Lancets
  • Testing Strips
  • Other Glucose Monitoring Devices

• Insulin Delivery Devices

• • Insulin Pens
  • Insulin Syringes
  • Insulin Pumps
  • Other Insulin Delivery Devices

By End User

• Hospitals & Clinics
• Homecare

By Geography

• North America
  • US
  • Canada
  • Mexico

Company Profiles

• BD
• Novo Nordisk A/S
• B. Braun Melsungen AG
• Insulet Corporation
• Medtronic
• Tandem Diabetes Care, Inc.
• Eli Lilly and Company
• Dexcom, Inc.
• Terumo Corporation
• F. Hoffman-LA Roche Ltd.

North America Diabetes Care Devices Report Scope